However, 12 patients harbored only one aberrant mutation in the TP53, KRAS, PIK3CA, or NRAS gene in their tumor tissues (Figure 2), emphasizing the dominant role of these genes in carcinogenesis. This evidence concerns the gene NRAS and neoplasm.